| Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis FX Blanc, T Sok, D Laureillard, L Borand, C Rekacewicz, E Nerrienet, ... New England Journal of Medicine 365 (16), 1471-1481, 2011 | 859 | 2011 |
| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 511 | 2020 |
| Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study FX Blanc, K Atassi, J Bignon, B Housset Chest 121 (5), 1677-1683, 2002 | 316 | 2002 |
| Clinical characteristics and prognostic factors of pulmonary MALT lymphoma R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ... European Respiratory Journal 34 (6), 1408-1416, 2009 | 251 | 2009 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 238 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 232 | 2020 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study GB Migliori, PM Thong, JW Alffenaar, J Denholm, M Tadolini, F Alyaquobi, ... European Respiratory Journal 58 (5), 2021 | 170 | 2021 |
| Efficacy of rituximab in refractory polymyositis. O Lambotte, R Kotb, G Maigne, FX Blanc, C Goujard, JF Delfraissy The Journal of Rheumatology 32 (7), 1369-1370, 2005 | 153 | 2005 |
| Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy G Foulon, M Wislez, JM Naccache, FX Blanc, A Rabbat, IB Dominique, ... Clinical infectious diseases 38 (3), 418-425, 2004 | 119 | 2004 |
| Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV … FX Blanc, T Sok, D Laureillard, L Borand, C Rekacewicz, E Nerrienet, ... XVIII International AIDS Conference, 18-23, 2010 | 104 | 2010 |
| On tuberculosis and COVID-19 co-infection M Tadolini, JM García-García, FX Blanc, S Borisov, D Goletti, I Motta, ... European Respiratory Journal 56 (2), 2020 | 103 | 2020 |
| Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan J Le Bel, P Hausfater, C Chenevier-Gobeaux, FX Blanc, M Benjoar, ... Critical Care 19, 1-12, 2015 | 95 | 2015 |
| Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial D Laureillard, O Marcy, Y Madec, S Chea, S Chan, L Borand, ... Aids 27 (16), 2577-2586, 2013 | 87 | 2013 |
| Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials FX Blanc, DV Havlir, PC Onyebujoh, S Thim, AE Goldfeld, JF Delfraissy The Journal of infectious diseases 196 (Supplement_1), S46-S51, 2007 | 77 | 2007 |
| Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial JM Naccache, S Jouneau, M Didier, R Borie, M Cachanado, A Bourdin, ... The Lancet Respiratory Medicine 10 (1), 26-34, 2022 | 74 | 2022 |
| Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial O Marcy, D Laureillard, Y Madec, S Chan, C Mayaud, L Borand, N Prak, ... Clinical infectious diseases 59 (3), 435-445, 2014 | 69 | 2014 |
| Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study A Menzies-Gow, ME Wechsler, CE Brightling, S Korn, J Corren, E Israel, ... The Lancet Respiratory Medicine 11 (5), 425-438, 2023 | 68 | 2023 |
| Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms … J Bertrand, C Verstuyft, M Chou, L Borand, P Chea, KH Nay, FX Blanc, ... The Journal of infectious diseases 209 (3), 399-408, 2014 | 66 | 2014 |
| Mechanics, energetics, and crossbridge kinetics of rabbit diaphragm during congestive heart failure Y Lecarpentier, D Chemla, FX Blanc, JC Pourny, T Joseph, B Riou, ... The FASEB journal 12 (11), 981-989, 1998 | 64 | 1998 |
| Mechanics and crossbridge kinetics of tracheal smooth muscle in two inbred rat strains FX Blanc, C Coirault, S Salmeron, D Chemla, Y Lecarpentier European Respiratory Journal 22 (2), 227-234, 2003 | 56 | 2003 |
